Chandrashekar Thalluri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chandrashekar Thalluri has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Sarad Pawar Naik Bukke
Victoria University
9 shared publications Mallikarjun Vasam
Department of Pharmaceutics, Omega College of Pharmacy, Osmania University, Hyderabad, India
5 shared publicationsJharna Medhi
Faculty of Pharmaceutical Science, Assam down town University (AdtU), Guwahati, India
3 shared publications- Kumara Swamy Samanthula
Department of Pharmaceutical Science, Assam Down Town University (AdtU)
3 shared publications Neha Gupta
Department of Pharmaceutics, Aligarh College of Pharmacy, Aligarh, India
3 shared publicationsAnanda Kumar Chettupalli
Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas Knowledge city Adamas University Kolkata West Bengal India
2 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Wiley in Precision Medical Sciences
Genomics and epigenomics of tissue repair: Implications for personalized medicine
The healing of tissues is a highly coordinated development process which includes cell proliferation and differentiation, immune modulation, and extracellular‐matrix remodeling. Genetic variation, which encompasses single‐nucleotide polymorphisms (SNPs) and copy‐number variations (CNVs), and epigenetic corrections such as DNA methylation, post‐translational changes to histones, and non‐coding RNA activity might impact regenerative capacity and individual response to injury. High‐throughput sequencing and molecular profiling technologies have made it feasible to conduct genome and epigenome‐wide studies, clarifying how genomic and epigenomic contributions impact reparative processes. For example, certain SNPs may alter signaling pathways that induce tissue growth and, likewise, epigenetic changes may alter gene‐expression patterns following injury that may affect healing. Furthermore, combining genomic and epigenomic data will allow for the development of therapies specific to an individual's capacity for repair and susceptibility for scarring. While biomarker discovery, the identification of molecular features that correlate with the efficiency of healing and/or responsiveness to treatment, would additionally provide a tangible example of precision regenerative medicine. Regenerative strategies targeting a genetic mutation or secondarily changing the epigenome to promote tissue healing would provide an opportunity to improve healing outcomes by connecting molecular mechanisms to therapeutic interventions, which would enhance regeneration while also minimizing fibrosis and other unwanted effects.
- 18 August 2026
- Published by Wiley in Precision Medical Sciences
Open AccessGenomics and epigenomics of tissue repair: Implications for personalized medicine
The healing of tissues is a highly coordinated development process which includes cell proliferation and differentiation, immune modulation, and extracellular‐matrix remodeling. Genetic variation, which encompasses single‐nucleotide polymorphisms (SNPs) and copy‐number variations (CNVs), and epigenetic corrections such as DNA methylation, post‐translational changes to histones, and non‐coding RNA activity might impact regenerative capacity and individual response to injury. High‐throughput sequencing and molecular profiling technologies have made it feasible to conduct genome and epigenome‐wide studies, clarifying how genomic and epigenomic contributions impact reparative processes. For example, certain SNPs may alter signaling pathways that induce tissue growth and, likewise, epigenetic changes may alter gene‐expression patterns following injury that may affect healing. Furthermore, combining genomic and epigenomic data will allow for the development of therapies specific to an individual's capacity for repair and susceptibility for scarring. While biomarker discovery, the identification of molecular features that correlate with the efficiency of healing and/or responsiveness to treatment, would additionally provide a tangible example of precision regenerative medicine. Regenerative strategies targeting a genetic mutation or secondarily changing the epigenome to promote tissue healing would provide an opportunity to improve healing outcomes by connecting molecular mechanisms to therapeutic interventions, which would enhance regeneration while also minimizing fibrosis and other unwanted effects.
- Open Access
- 27 July 2026
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 25 (1)
AI-integrated nanomaterial-based biosensors for biomedical diagnostics: engineering design, signal processing, and clinical translation
Nanobiosensor platforms based on nanomaterials have the potential to change the future of biomedical diagnostics with highly sensitive detection as well as
- 27 July 2026
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 25 (1)
Open AccessAI-integrated nanomaterial-based biosensors for biomedical diagnostics: engineering design, signal processing, and clinical translation
Nanobiosensor platforms based on nanomaterials have the potential to change the future of biomedical diagnostics with highly sensitive detection as well as
- 4 July 2026
- Published by Taylor & Francis in Personalized Medicine
- Vol. 23 (4) , 411-426
Engineering innovations for precision medicine: sensors, AI biomarkers, and predictive interventions
1. Precision medicine represents a major shift in how diseases are treated with a more customized approach than what is currently available. When patients have measurable biological, physiological,...
- 4 July 2026
- Published by Taylor & Francis in Personalized Medicine
- Vol. 23 (4) , 411-426
Engineering innovations for precision medicine: sensors, AI biomarkers, and predictive interventions
1. Precision medicine represents a major shift in how diseases are treated with a more customized approach than what is currently available. When patients have measurable biological, physiological,...
- 9 June 2026
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- p. 1-34
Advanced drug delivery systems for regenerative medicine: nanobiomaterial innovations, hybrid platforms, and translational perspectives
Regenerative therapies focus on repairing, reproducing, or regenerating tissues and organs that have been harmed due to injury or illness through cellular based therapy and bioactive molecule driven systems. The advancement of this type of therapy has become increasingly dependent on progressive developments in drug delivery systems that provide controlled and sustained delivery of therapeutic agents and modulated the cellular behaviors in the target site. Nanocarriers (liposomes, extracellular vesicles, etc.) increase the biocompatibility of the drug delivery system and aid in the targeted delivery of growth factors and genetic materials. Additionally, advanced biomaterials (hydrogels, bioresorbable polymers) serve as drug delivery vehicle for the regeneration of the tissues while acting as structural scaffold to create a regenerative microenvironment. New technologies (3D cell printing, micro-fluidic systems) provide excellent ability to precisely control the spatial deployment of therapeutic agents thereby enhancing local tissue regeneration and angiogenesis. While many of these modalities have demonstrated success in preclinical studies, there are still many challenges constraining the large-scale manufacture, standardization and regulatory approval for translation into the clinic. Therefore, there is a critical need for multidisciplinary collaborative efforts to further develop scalable and effective personalized regenerative therapies to treat patients with regenerative medicine. This review proposes a hierarchical framework integrating nano-scale carriers, biomaterial platforms, and therapeutic applications, offering a unified perspective that bridges material innovation with clinical translation in regenerative medicine.
- 9 June 2026
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- p. 1-34
Advanced drug delivery systems for regenerative medicine: nanobiomaterial innovations, hybrid platforms, and translational perspectives
Regenerative therapies focus on repairing, reproducing, or regenerating tissues and organs that have been harmed due to injury or illness through cellular based therapy and bioactive molecule driven systems. The advancement of this type of therapy has become increasingly dependent on progressive developments in drug delivery systems that provide controlled and sustained delivery of therapeutic agents and modulated the cellular behaviors in the target site. Nanocarriers (liposomes, extracellular vesicles, etc.) increase the biocompatibility of the drug delivery system and aid in the targeted delivery of growth factors and genetic materials. Additionally, advanced biomaterials (hydrogels, bioresorbable polymers) serve as drug delivery vehicle for the regeneration of the tissues while acting as structural scaffold to create a regenerative microenvironment. New technologies (3D cell printing, micro-fluidic systems) provide excellent ability to precisely control the spatial deployment of therapeutic agents thereby enhancing local tissue regeneration and angiogenesis. While many of these modalities have demonstrated success in preclinical studies, there are still many challenges constraining the large-scale manufacture, standardization and regulatory approval for translation into the clinic. Therefore, there is a critical need for multidisciplinary collaborative efforts to further develop scalable and effective personalized regenerative therapies to treat patients with regenerative medicine. This review proposes a hierarchical framework integrating nano-scale carriers, biomaterial platforms, and therapeutic applications, offering a unified perspective that bridges material innovation with clinical translation in regenerative medicine.
- Open Access
- 16 December 2025
- Published by Taylor & Francis in Materials Technology
- Vol. 40 (1)
Redefining detection with nanobiosensors: exploring sensor types, fabrication techniques, and multi-scale applications
- 16 December 2025
- Published by Taylor & Francis in Materials Technology
- Vol. 40 (1)
Open AccessRedefining detection with nanobiosensors: exploring sensor types, fabrication techniques, and multi-scale applications
- Open Access
- 2 December 2025
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 25 (1)
The future of vesicular drug delivery: transferosomes in therapeutic advancement—applications, innovations and challenges
Transferosomes represent a novel vesicular drug delivery system developed to overcome the limitations of traditional transdermal systems. These ultra-defor
- 2 December 2025
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 25 (1)
Open AccessThe future of vesicular drug delivery: transferosomes in therapeutic advancement—applications, innovations and challenges
Transferosomes represent a novel vesicular drug delivery system developed to overcome the limitations of traditional transdermal systems. These ultra-defor
- Open Access
- 30 September 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (11) , 7759-7762
Traumatic testicular rupture complicated by pyocele: a rare case report
Introduction and Importance: Scrotal pyocele is a rare but serious urological emergency characterized by the accumulation of purulent fluid within the scrotum, often secondary to infection or trauma. Early recognition and intervention are essential to prevent complications such as abscess formation, necrosis, or testicular loss. Case Presentation: We report the case of a 39-year-old diabetic male with chronic alcoholism who presented with progressive left scrotal pain and swelling following a minor motorcycle accident. Ultrasonography confirmed rupture of the tunica vaginalis and collection of purulent fluid consistent with pyocele. Emergency incision and drainage were performed, and pus culture revealed Staphylococcus aureus , which was managed successfully with targeted antibiotics and analgesics. The patient recovered completely without complications. Clinical Discussion: Scrotal pyocele is an uncommon sequela of blunt trauma, more often associated with infectious etiologies. In this case, ultrasonography played a crucial role in differentiating pyocele from hematocele and guiding early surgical intervention. The presence of comorbidities such as diabetes and chronic alcoholism increased infection risk, yet timely drainage and culture-directed therapy led to preservation of testicular function. The isolation of S. aureus is unusual compared to more typical urinary pathogens reported in previous literature. Conclusion: Traumatic scrotal pyocele is a rare but potentially life-threatening entity. Prompt diagnosis, surgical drainage, and culture-based antibiotic therapy are critical to favorable outcomes and testicular preservation.
- 30 September 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (11) , 7759-7762
Open AccessTraumatic testicular rupture complicated by pyocele: a rare case report
Introduction and Importance: Scrotal pyocele is a rare but serious urological emergency characterized by the accumulation of purulent fluid within the scrotum, often secondary to infection or trauma. Early recognition and intervention are essential to prevent complications such as abscess formation, necrosis, or testicular loss. Case Presentation: We report the case of a 39-year-old diabetic male with chronic alcoholism who presented with progressive left scrotal pain and swelling following a minor motorcycle accident. Ultrasonography confirmed rupture of the tunica vaginalis and collection of purulent fluid consistent with pyocele. Emergency incision and drainage were performed, and pus culture revealed Staphylococcus aureus , which was managed successfully with targeted antibiotics and analgesics. The patient recovered completely without complications. Clinical Discussion: Scrotal pyocele is an uncommon sequela of blunt trauma, more often associated with infectious etiologies. In this case, ultrasonography played a crucial role in differentiating pyocele from hematocele and guiding early surgical intervention. The presence of comorbidities such as diabetes and chronic alcoholism increased infection risk, yet timely drainage and culture-directed therapy led to preservation of testicular function. The isolation of S. aureus is unusual compared to more typical urinary pathogens reported in previous literature. Conclusion: Traumatic scrotal pyocele is a rare but potentially life-threatening entity. Prompt diagnosis, surgical drainage, and culture-based antibiotic therapy are critical to favorable outcomes and testicular preservation.
- Open Access
- 7 September 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 499-509
TRANSMUCOSAL BUCCAL PATCHES CARRYING BENIDIPINE HYDROCHLORIDE WITH A UNIDIRECTIONAL RELEASE OPTIMIZED BY CENTRAL COMPOSITE DESIGN
Objective: This investigation aimed to develop buccal patches of benidipine hydrochloride (BH) that provide unidirectional release and adhere well to the mucous membranes. Methods: The buccal patches of BH with a unidirectional drug release were made utilizing the solvent casting process using hydroxy propyl methyl cellulose, eudragit RL 100, and polyvinylpyrrolidone. The patches' water-resistant backing layer allowed for the controlled delivery of medication in one direction. Thickness, mass, surface pH, folding endurance, moisture absorption, in vitro release, ex-vivo permeation release, and accelerated stability experiments were all used to assess them. Results: Based on the optimized formulation, the moisture absorption percentage is 40.50±1.39%, whereas the range for the original formulation was 32.18±1.69% to 44.95±1.52%. According to the in vitro drug release assays, formulation F9 was able to release 99.86±1.39% of the medication until 6 h. The study found progressive and constant drug penetration, with 69.53±1.86 compared to 54.88±1.39% in 6 h from the improved formulation. Conclusion: A possible alternative drug delivery strategy for the systemic distribution of BH was suggested by the manufactured unidirectional buccal patches of BH, which released the maximal amount of medication during the prescribed mucoadhesion duration.
- 7 September 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 499-509
Open AccessTRANSMUCOSAL BUCCAL PATCHES CARRYING BENIDIPINE HYDROCHLORIDE WITH A UNIDIRECTIONAL RELEASE OPTIMIZED BY CENTRAL COMPOSITE DESIGN
Objective: This investigation aimed to develop buccal patches of benidipine hydrochloride (BH) that provide unidirectional release and adhere well to the mucous membranes. Methods: The buccal patches of BH with a unidirectional drug release were made utilizing the solvent casting process using hydroxy propyl methyl cellulose, eudragit RL 100, and polyvinylpyrrolidone. The patches' water-resistant backing layer allowed for the controlled delivery of medication in one direction. Thickness, mass, surface pH, folding endurance, moisture absorption, in vitro release, ex-vivo permeation release, and accelerated stability experiments were all used to assess them. Results: Based on the optimized formulation, the moisture absorption percentage is 40.50±1.39%, whereas the range for the original formulation was 32.18±1.69% to 44.95±1.52%. According to the in vitro drug release assays, formulation F9 was able to release 99.86±1.39% of the medication until 6 h. The study found progressive and constant drug penetration, with 69.53±1.86 compared to 54.88±1.39% in 6 h from the improved formulation. Conclusion: A possible alternative drug delivery strategy for the systemic distribution of BH was suggested by the manufactured unidirectional buccal patches of BH, which released the maximal amount of medication during the prescribed mucoadhesion duration.
- Open Access
- 27 May 2025
- Published by Springer Nature in Discover Applied Sciences
- Vol. 7 (6) , 1-37
The role of genomics and proteomics in drug discovery and its application in pharmacy
- 27 May 2025
- Published by Springer Nature in Discover Applied Sciences
- Vol. 7 (6) , 1-37
Open AccessThe role of genomics and proteomics in drug discovery and its application in pharmacy